Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008:2008:102737.
doi: 10.1155/2008/102737.

The Role of PPARs in Cancer

Keisuke Tachibana  1 , Daisuke Yamasaki, Kenji Ishimoto, Takefumi Doi
Affiliations

The Role of PPARs in Cancer

Keisuke Tachibana et al. PPAR Res. 2008.

Abstract

Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that belong to the nuclear hormone receptor superfamily. PPARalpha is mainly expressed in the liver, where it activates fatty acid catabolism. PPARalpha activators have been used to treat dyslipidemia, causing a reduction in plasma triglyceride and elevation of high-density lipoprotein cholesterol. PPARdelta is expressed ubiquitously and is implicated in fatty acid oxidation and keratinocyte differentiation. PPARdelta activators have been proposed for the treatment of metabolic disease. PPARgamma2 is expressed exclusively in adipose tissue and plays a pivotal role in adipocyte differentiation. PPARgamma is involved in glucose metabolism through the improvement of insulin sensitivity and represents a potential therapeutic target of type 2 diabetes. Thus PPARs are molecular targets for the development of drugs treating metabolic syndrome. However, PPARs also play a role in the regulation of cancer cell growth. Here, we review the function of PPARs in tumor growth.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The general features of human PPARs. (a) Structure and functional domain of human PPARs. A/B, C, D, and E/F indicate N-terminal A/B domain containing a ligand-independent activation function 1, DNA-binding domain (DBD), hinge region, and C-terminal ligand-binding domain (LBD), respectively. The number inside each domain corresponds to the percentage of amino acid sequence identity of human PPARδ and PPARγ relative to PPARα. (b) PPAR/RXR heterodimers bind to a PPRE located in the promoter of target genes through the DBD. Unliganded PPAR associates with the corepressor complex. In the presence of ligand, the ligand-bound LBD associates with the coactivator complex.
Figure 2
Figure 2
Does PPARδ progress or suppress tumor growth?
See this image and copyright information in PMC

References

    1. Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell. 1995;83(6):835–839. - PMC - PubMed
    1. Hsu M-H, Palmer CNA, Song W, Griffin KJ, Johnson EF. A carboxyl-terminal extension of the zinc finger domain contributes to the specificity and polarity of peroxisome proliferator-activated receptor DNA binding. Journal of Biological Chemistry. 1998;273(43):27988–27997. - PubMed
    1. Gervois P, Chopin-Delannoy S, Fadel A, et al. Fibrates increase human REV-ERBα expression in liver via a novel peroxisome proliferator-activated receptor response element. Molecular Endocrinology. 1999;13(3):400–409. - PubMed
    1. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature. 1992;358(6389):771–774. - PMC - PubMed
    1. Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. Journal of Lipid Research. 1996;37(5):907–925. - PubMed

LinkOut - more resources